Research Fellow in Pediatrics (EXT)
Boston Children's Hospital
Dana-Farber Cancer Institute
450 Brookline Ave
Boston MA 02215
|Peter MacCallum Cancer Centre & University of Melbourne, Melbourne, Australia||PhD||2021||Hematology/Oncology, Cancer Biology|
|University of Melbourne, Melbourne, Australia||BSc (Hons)||2016||Pathology|
The University of Melbourne Chancellor’s Prize for Best PhD Thesis (Nominated)
Regeneron Scholars Program
2021 - 2022
Cancer Council Victoria Postdoctoral Cancer Research Fellowship
Victorian Comprehensive Cancer Centre (VCCC) Picchi Award for Excellence in Cancer Research
Keystone Symposia Future of Science Fund Scholarship
European Haematology Association (EHA) Travel Grant
International Society for Experimental Haematology (ISEH) Travel Grant
2017 - 2020
Australian Government Research Training Program Scholarship
2017 - 2020
Robert Kirby Peter MacCallum Foundation Post Graduate Award
2010 - 2013
Kwong Lee Dow Young Scholar
I am a Research Fellow in Pediatrics in the Department of Pediatric Oncology at Dana-Farber Cancer Institute, with co-appointments at Harvard Medical School and The Broad Institute of MIT and Harvard, based in Boston, MA. My research is centered on pediatric hematological malignancies, and the discovery of new cancer targets and small-molecule therapeutic leads in the laboratory of Professor Kimberly Stegmaier (Vice Chair of Pediatric Oncology Research and Co-Director, Pediatric Hematologic Malignancy Program, Dana-Farber Cancer Institute and Boston Children's Hospital).
I received my doctorate under the mentorship of Professor Ricky Johnstone (Executive Director of Cancer Research) and Dr Gareth Gregory at the Peter MacCallum Cancer Centre and The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. My doctoral work focussed on dissecting metabolic rewiring mediated by FLT3-ITD, one of the most common mutations in acute myeloid leukemia (AML), and uncovered a targetable dependency in this aggressive subset of AML. This work was published in the top journal Cancer Discovery in 2021.
My postdoctoral work builds on my previous training by extending my expertise in AML model generation and characterization, large-scale genetic screening, transcription, epigenetics, cellular metabolism, and use of in vivo models for therapeutic validation.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.